Hoe verhoudt WALPAR's PE Ratio zich tot zijn concurrenten?

WALPAR is good value based on its Price-To-Earnings Ratio (28.6x) compared to the peer average (31.6x).

Hoe verhoudt WALPAR's PE Ratio zich tot andere bedrijven in de IN Personal Products industrie?

WALPAR is expensive based on its Price-To-Earnings Ratio (28.6x) compared to the Asian Personal Products industry average (25.2x).

Wat is WALPAR's PE Ratio vergeleken met zijn Fair PE Ratio? Dit is de verwachte PE Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

Insufficient data to calculate WALPAR's Price-To-Earnings Fair Ratio for valuation analysis.

Wat is de reële prijs van WALPAR als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

Insufficient data to calculate WALPAR's fair value for valuation analysis.

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

Insufficient data to show price forecast.

Walpar Nutritions (NSEI:WALPAR) - Aandelenkoers, Nieuws & Analyse

WALPAR Overzicht aandelen

Walpar Nutritions Limited houdt zich bezig met de productie van en handel in farmaceutische, nutraceutische, kruiden- en ayurvedische producten.

Over het bedrijf

WALPAR fundamentele analyse
Sneeuwvlok Score
Waardering	1/6
Toekomstige groei	0/6
Prestaties in het verleden	5/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

Price-To-Earnings ratio (28.6x) is below the Indian market (33.3x)

Earnings grew by 168.1% over the past year

Risicoanalyse

Does not have a meaningful market cap (₹453M)

Has a high level of debt

Significant insider selling over the past 3 months

Volatile share price over the past 3 months compared to the Indian market

Walpar Nutritions Limited Concurrenten

Deccan Health Care

BSE:542248

₹542.4m

Sandu Pharmaceuticals

BSE:524703

₹544.2m

Lykis

BSE:530689

₹900.8m

Unjha Formulations

BSE:531762

₹142.7m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Walpar Nutritions
Historische aandelenkoersen
Huidige aandelenkoers	₹49.90
52 Week Hoogtepunt	₹76.98
52 Week Laag	₹39.00
Bèta	-0.57
11 maand verandering	2.46%
3 maanden verandering	-19.19%
1 Jaar Verandering	20.97%
33 jaar verandering	186.78%
5 jaar verandering	n/a
Verandering sinds IPO	75.09%

Recent nieuws en updates

Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Sep 28

Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?

Sep 07

Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost

Jul 27

Recent updates

Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Sep 28

Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?

Sep 07

Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost

Jul 27

With EPS Growth And More, Walpar Nutritions (NSE:WALPAR) Makes An Interesting Case

Feb 14

Here's Why Walpar Nutritions (NSE:WALPAR) Has Caught The Eye Of Investors

Sep 18

We Ran A Stock Scan For Earnings Growth And Walpar Nutritions (NSE:WALPAR) Passed With Ease

May 25

If EPS Growth Is Important To You, Walpar Nutritions (NSE:WALPAR) Presents An Opportunity

Sep 29

Walpar Nutritions Limited's (NSE:WALPAR) P/E Is Still On The Mark Following 26% Share Price Bounce

Jul 22

Rendement voor aandeelhouders

	WALPAR	IN Personal Products	IN Markt
7D	9.4%	0.6%	1.8%
1Y	21.0%	8.1%	36.8%

Rendement versus industrie: WALPAR exceeded the Indian Personal Products industry which returned 8.2% over the past year.

Rendement versus markt: WALPAR underperformed the Indian Market which returned 37.9% over the past year.

Prijsvolatiliteit

Is WALPAR's price volatile compared to industry and market?
WALPAR volatility
WALPAR Average Weekly Movement	7.9%
Personal Products Industry Average Movement	4.4%
Market Average Movement	6.3%
10% most volatile stocks in IN Market	9.4%
10% least volatile stocks in IN Market	4.0%

Stabiele aandelenkoers: WALPAR's share price has been volatile over the past 3 months compared to the Indian market.

Volatiliteit in de loop van de tijd: WALPAR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2009	n/a	Kalpesh Ladhawala	www.walparnutritions.com

Walpar Nutritions Limited houdt zich bezig met de productie van en handel in farmaceutische, nutraceutische, kruiden- en ayurvedische producten. Het is ook betrokken bij de contractproductie van nutraceutische en kruidenproducten; en de handel in grondstoffen die worden gebruikt bij de productie van nutraceutische producten. Het bedrijf werd opgericht in 2009 en is gevestigd in Gandhinagar, India.

Walpar Nutritions Limited Samenvatting

Hoe verhouden de winst en inkomsten van Walpar Nutritions zich tot de beurswaarde?
WALPAR fundamentele statistieken
Marktkapitalisatie	₹453.21m
Inkomsten(TTM)	₹15.82m
Inkomsten(TTM)	₹627.40m

28.6x

Koers/Winstverhouding

0.7x

P/S-verhouding

Is WALPAR overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
WALPAR resultatenrekening (TTM)
Inkomsten	₹627.40m
Kosten van inkomsten	₹497.84m
Brutowinst	₹129.56m
Overige uitgaven	₹113.74m
Inkomsten	₹15.82m

Laatst gerapporteerde inkomsten

Mar 31, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	1.74
Brutomarge	20.65%
Nettowinstmarge	2.52%
Schuld/Eigen Vermogen Verhouding	50.5%

Hoe presteerde WALPAR op de lange termijn?

Bekijk historische prestaties en vergelijking

WALPAR Overzicht aandelen

Beloningen

Risicoanalyse

Walpar Nutritions Limited Concurrenten

BSE:542248

₹542.4m

BSE:524703

₹544.2m

BSE:530689

₹900.8m

BSE:531762

₹142.7m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Investor sentiment deteriorates as stock falls 17%

Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?

Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost

Walpar Nutritions Limited, Annual General Meeting, Jul 30, 2024

Walpar Nutritions Limited, Annual General Meeting, Jul 30, 2024

Recent updates

Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Investor sentiment deteriorates as stock falls 17%

Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?

Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost

Walpar Nutritions Limited, Annual General Meeting, Jul 30, 2024

Walpar Nutritions Limited, Annual General Meeting, Jul 30, 2024

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 18%

New minor risk - Financial data availability

New major risk - Share price stability

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 17%

With EPS Growth And More, Walpar Nutritions (NSE:WALPAR) Makes An Interesting Case

Investor sentiment improves as stock rises 19%

First half 2024 earnings released

Full year 2023 earnings released: EPS: ₹1.30 (vs ₹0.90 in FY 2022)

Walpar Nutritions Limited, Annual General Meeting, Sep 26, 2023

Here's Why Walpar Nutritions (NSE:WALPAR) Has Caught The Eye Of Investors

Investor sentiment improves as stock rises 15%

We Ran A Stock Scan For Earnings Growth And Walpar Nutritions (NSE:WALPAR) Passed With Ease

Full year 2023 earnings released: EPS: ₹2.51 (vs ₹0.90 in FY 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment improved over the past week

If EPS Growth Is Important To You, Walpar Nutritions (NSE:WALPAR) Presents An Opportunity

Investor sentiment improved over the past week

Walpar Nutritions Limited's (NSE:WALPAR) P/E Is Still On The Mark Following 26% Share Price Bounce

Investor sentiment improved over the past week

Executive Director & CFO recently bought ₹2.4m worth of stock

Walpar Nutritions Limited Announces Resignation of Mr. Parin Patel from the Post of Independent Director

Company Secretary & Compliance Officer Palakben Joshi has left the company

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Walpar Nutritions Limited Samenvatting

28.6x

0.7x

Inkomsten en omzet